Brian J. Wells
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Brian J. Wells has a total of 258 co-authors. Here are the top co-authors by number of shared publications:
- Michael W. Kattan
Cleveland Clinic, Cleveland, Ohio
24 shared publications Changhong Yu
Department of Quantitative Health Sciences, Cleveland Clinic, Cleveland, OH
14 shared publications- Arch G. Mainous
Department of Community Health and Family Medicine, University of Florida
9 shared publications - Kristin Macfarlane Lenoir
Department of Biostatistics and Data Science, Wake Forest University School of Medicine, Winston-Salem, North Carolina
9 shared publications - Kevin Matthew Pantalone
Center for Quantitative Metabolic Research Cleveland Clinic Cleveland Ohio USA
8 shared publications Susana Arrigain
Department of Quantitative Health Sciences, Cleveland Clinic, Cleveland, OH, United States
7 shared publications
Latest Publications
- Open Access
Obesity in the GLP-1 Era: Clinical Characteristics and Prescribing Patterns in a Large Integrated Health System
Structured Aims: To characterize adults with obesity in a large integrated health system. Methods: We created a cross-sectional cohort of adults with at least one body mass index (BMI) value >=30 kg/m2 in the prior 18 months, a recent in-person outpatient visit, and an assigned primary care provider. Electronic health record data were transformed into a patient-level analytic dataset and linked to neighborhood-level social determinants of health. Diagnoses, laboratory values, vital signs, and prescriptions were curated using reproducible phenotype definitions and internally reviewed vocabularies. Results: The registry included 280,186 adults, of whom 48% had class I obesity. The cohort was 63% female, 27% Black, and 14% lived in areas with high or very high deprivation. Common comorbidities included hypertension, type 2 diabetes, depression, and anxiety. HbA1c and cholesterol measurements were absent in more than 40% of the cohort during the prior two years. Overall, 22% of patients received a prescription for at least one weight loss drug in the past 2 years, including 18% who received a weight-loss-approved GLP-1 receptor agonist. Conclusions: This care-engaged obesity cohort was characterized by high representation of women and socially vulnerable populations, substantial cardiometabolic screening gaps, and broad adoption of GLP-1 agonists.
Open AccessObesity in the GLP-1 Era: Clinical Characteristics and Prescribing Patterns in a Large Integrated Health System
Structured Aims: To characterize adults with obesity in a large integrated health system. Methods: We created a cross-sectional cohort of adults with at least one body mass index (BMI) value >=30 kg/m2 in the prior 18 months, a recent in-person outpatient visit, and an assigned primary care provider. Electronic health record data were transformed into a patient-level analytic dataset and linked to neighborhood-level social determinants of health. Diagnoses, laboratory values, vital signs, and prescriptions were curated using reproducible phenotype definitions and internally reviewed vocabularies. Results: The registry included 280,186 adults, of whom 48% had class I obesity. The cohort was 63% female, 27% Black, and 14% lived in areas with high or very high deprivation. Common comorbidities included hypertension, type 2 diabetes, depression, and anxiety. HbA1c and cholesterol measurements were absent in more than 40% of the cohort during the prior two years. Overall, 22% of patients received a prescription for at least one weight loss drug in the past 2 years, including 18% who received a weight-loss-approved GLP-1 receptor agonist. Conclusions: This care-engaged obesity cohort was characterized by high representation of women and socially vulnerable populations, substantial cardiometabolic screening gaps, and broad adoption of GLP-1 agonists.
- Open Access
- 5 May 2026
- Published by Oxford University Press (OUP) in JAMIA Open
- Vol. 9 (3) , ooag080
Using large language models to enhance clinically-driven missing data recovery algorithms in electronic health records
Objectives: Electronic health record (EHR) data are prone to missingness and errors. Previously, we devised an enriched chart review protocol where a “roadmap” of auxiliary diagnoses was used to recover missing values. Still, chart reviews are expensive and time-intensive, limiting the number of patients whose data can be reviewed. Now, we investigate the accuracy and scalability of a roadmap-driven algorithm, based on International Classification of Diseases, 10th revision (ICD-10) codes, to mimic expert chart reviews and recover missing values. Materials and Methods: In addition to the clinicians’ original roadmap from our previous work, we consider new versions that were iteratively refined using large language models (LLMs) in conjunction with clinical expertise to expand the list of auxiliary diagnoses. Using chart reviews for 100 patients from an extensive EHR, we examine algorithm performance. Results: Across 100 chart reviewed patients, there were 413 missing values in the EHR data. The expert chart reviews recovered 49 (12%), while the algorithms using LLMs-enhanced roadmaps recommended almost twice as many (83-89, 20%-22%). The final algorithm using clinician-approved LLMs’ additions offered a balance (73, 18%), expanding the original roadmap with LLMs’ suggestions but only when deemed clinically relevant. When applied to a larger study of 1000 patients from the same EHR, the per-patient median number of non-missing values increased from 6 to 7. Discussion: Clinically-driven algorithms (enhanced by LLMs) can recover missing EHR data with similar accuracy to chart reviews and feasibly be applied to large samples. Extending them to monitor other data quality dimensions is a promising future direction.
- 5 May 2026
- Published by Oxford University Press (OUP) in JAMIA Open
- Vol. 9 (3) , ooag080
Open AccessUsing large language models to enhance clinically-driven missing data recovery algorithms in electronic health records
Objectives: Electronic health record (EHR) data are prone to missingness and errors. Previously, we devised an enriched chart review protocol where a “roadmap” of auxiliary diagnoses was used to recover missing values. Still, chart reviews are expensive and time-intensive, limiting the number of patients whose data can be reviewed. Now, we investigate the accuracy and scalability of a roadmap-driven algorithm, based on International Classification of Diseases, 10th revision (ICD-10) codes, to mimic expert chart reviews and recover missing values. Materials and Methods: In addition to the clinicians’ original roadmap from our previous work, we consider new versions that were iteratively refined using large language models (LLMs) in conjunction with clinical expertise to expand the list of auxiliary diagnoses. Using chart reviews for 100 patients from an extensive EHR, we examine algorithm performance. Results: Across 100 chart reviewed patients, there were 413 missing values in the EHR data. The expert chart reviews recovered 49 (12%), while the algorithms using LLMs-enhanced roadmaps recommended almost twice as many (83-89, 20%-22%). The final algorithm using clinician-approved LLMs’ additions offered a balance (73, 18%), expanding the original roadmap with LLMs’ suggestions but only when deemed clinically relevant. When applied to a larger study of 1000 patients from the same EHR, the per-patient median number of non-missing values increased from 6 to 7. Discussion: Clinically-driven algorithms (enhanced by LLMs) can recover missing EHR data with similar accuracy to chart reviews and feasibly be applied to large samples. Extending them to monitor other data quality dimensions is a promising future direction.
- Open Access
- 1 January 2026
- Published by Taylor & Francis in International Journal of Chronic Obstructive Pulmonary Disease
- Vol. ume 21, 1-12
Development and Validation of an Electronic Health Record Algorithm to Predict the Presence of Chronic Obstructive Pulmonary Disease
Purpose: Chronic obstructive pulmonary disease (COPD) is frequently diagnosed and treated based on clinical suspicion alone, without spirometric confirmation of expiratory airflow obstruction (AFO, defined by a forced expiratory volume in 1 second (FEV1) to forced vital capacity (FVC) ratio of < 0.7). This can lead to overdiagnosis and unnecessary medication use, whereas underdiagnosis results in missed treatment opportunities. The Global Initiative for Chronic Obstructive Lung Disease (GOLD) recommends targeted case finding. This study aimed to develop and validate an automated Electronic Health Record (EHR) based algorithm to predict AFO and guide targeted spirometric testing. Patients and Methods: Our analysis included 15,065 patients who underwent pulmonary function testing between 2016– 2022. Patients were categorized as having AFO (n=4632) or not (n=10,433) based on spirometry. Patients < 45 years, with cystic fibrosis, alpha-1 antitrypsin deficiency, or prior spirometric evidence of obstruction were excluded. Logistic regression assessed 65 variables, retaining those that optimized model discrimination. The data were randomly split into training (n=10,546) and validation (n=4519) sets. Results: Key predictors of AFO included older age, male sex, lower BMI, smoking history, prior COPD diagnosis, increased emergency department utilization, fewer outpatient visits, fewer chest X-rays, and higher cumulative beta-agonist prescriptions. The final model achieved an area under the receiver operating characteristic curve (AUC) of 0.82 (95% CI: 0.81– 0.83) in the validation dataset and was well calibrated. Conclusion: We developed an EHR-based algorithm that accurately predicts AFO using routinely collected structured data. This tool provides a practical method for identifying patients for targeted COPD case finding. Future efforts will focus on external validation and integration into clinical workflows, enabling automated identification and provider or patient notification to facilitate appropriate pulmonary function testing. Plain Language Summary: Researchers at the Wake Forest University School of Medicine found patterns in computerized medical records that can help identify patients with undiagnosed chronic obstructive pulmonary disease (COPD). Finding patients with possible COPD allows for testing, earlier diagnosis, and treatment before the disease becomes severe. COPD is a group of lung diseases (such as emphysema) that make it difficult to breathe. Although many people with COPD have a history of smoking, there are other risk factors as well. It is estimated that about 60% of people with COPD do not know they have it. COPD can be diagnosed easily with a painless breathing test called spirometry, which only takes a few minutes in a doctor’s office. This new tool can automatically find patients who should be tested for COPD without needing them to fill out symptom questionnaires. It uses statistics to combine information such as age, sex, weight, height, and smoking history with data on past prescriptions, chest x-rays, and emergency department visits. The researchers hope that, in the future, patients might be notified about their risk and have the test done even before seeing their doctor. Early diagnosis allows people to get vaccines that protect their lungs and to start medicines that can help prevent serious health problems. By using this tool, doctors can help more patients get the care they need sooner.
- 1 January 2026
- Published by Taylor & Francis in International Journal of Chronic Obstructive Pulmonary Disease
- Vol. ume 21, 1-12
Open AccessDevelopment and Validation of an Electronic Health Record Algorithm to Predict the Presence of Chronic Obstructive Pulmonary Disease
Purpose: Chronic obstructive pulmonary disease (COPD) is frequently diagnosed and treated based on clinical suspicion alone, without spirometric confirmation of expiratory airflow obstruction (AFO, defined by a forced expiratory volume in 1 second (FEV1) to forced vital capacity (FVC) ratio of < 0.7). This can lead to overdiagnosis and unnecessary medication use, whereas underdiagnosis results in missed treatment opportunities. The Global Initiative for Chronic Obstructive Lung Disease (GOLD) recommends targeted case finding. This study aimed to develop and validate an automated Electronic Health Record (EHR) based algorithm to predict AFO and guide targeted spirometric testing. Patients and Methods: Our analysis included 15,065 patients who underwent pulmonary function testing between 2016– 2022. Patients were categorized as having AFO (n=4632) or not (n=10,433) based on spirometry. Patients < 45 years, with cystic fibrosis, alpha-1 antitrypsin deficiency, or prior spirometric evidence of obstruction were excluded. Logistic regression assessed 65 variables, retaining those that optimized model discrimination. The data were randomly split into training (n=10,546) and validation (n=4519) sets. Results: Key predictors of AFO included older age, male sex, lower BMI, smoking history, prior COPD diagnosis, increased emergency department utilization, fewer outpatient visits, fewer chest X-rays, and higher cumulative beta-agonist prescriptions. The final model achieved an area under the receiver operating characteristic curve (AUC) of 0.82 (95% CI: 0.81– 0.83) in the validation dataset and was well calibrated. Conclusion: We developed an EHR-based algorithm that accurately predicts AFO using routinely collected structured data. This tool provides a practical method for identifying patients for targeted COPD case finding. Future efforts will focus on external validation and integration into clinical workflows, enabling automated identification and provider or patient notification to facilitate appropriate pulmonary function testing. Plain Language Summary: Researchers at the Wake Forest University School of Medicine found patterns in computerized medical records that can help identify patients with undiagnosed chronic obstructive pulmonary disease (COPD). Finding patients with possible COPD allows for testing, earlier diagnosis, and treatment before the disease becomes severe. COPD is a group of lung diseases (such as emphysema) that make it difficult to breathe. Although many people with COPD have a history of smoking, there are other risk factors as well. It is estimated that about 60% of people with COPD do not know they have it. COPD can be diagnosed easily with a painless breathing test called spirometry, which only takes a few minutes in a doctor’s office. This new tool can automatically find patients who should be tested for COPD without needing them to fill out symptom questionnaires. It uses statistics to combine information such as age, sex, weight, height, and smoking history with data on past prescriptions, chest x-rays, and emergency department visits. The researchers hope that, in the future, patients might be notified about their risk and have the test done even before seeing their doctor. Early diagnosis allows people to get vaccines that protect their lungs and to start medicines that can help prevent serious health problems. By using this tool, doctors can help more patients get the care they need sooner.
- Open Access
- 6 March 2025
- Published by JMIR Publications Inc. in Journal of Medical Internet Research
- Vol. 27, e65152
Oncology Provider and Patient Perspectives on a Cardiovascular Health Assessment Tool Used During Posttreatment Survivorship Care in Community Oncology (Results from WF-1804CD): Mixed Methods Observational Study
Background: Most survivors of cancer have multiple cardiovascular risk factors, increasing their risk of poor cardiovascular and cancer outcomes. The Automated Heart-Health Assessment (AH-HA) tool is a novel electronic health record clinical decision support tool based on the American Heart Association’s Life’s Simple 7 cardiovascular health metrics to promote cardiovascular health assessment and discussion in outpatient oncology. Before proceeding to future implementation trials, it is critical to establish the acceptability of the tool among providers and survivors. Objective: This study aims to assess provider and survivor acceptability of the AH-HA tool and provider training at practices randomized to the AH-HA tool arm within WF-1804CD. Methods: Providers (physicians, nurse practitioners, and physician assistants) completed a survey to assess the acceptability of the AH-HA training, immediately following training. Providers also completed surveys to assess AH-HA tool acceptability and potential sustainability. Tool acceptability was assessed after 30 patients were enrolled at the practice with both a survey developed for the study as well as with domains from the Unified Theory of Acceptance and Use of Technology survey (performance expectancy, effort expectancy, attitude toward using technology, and facilitating conditions). Semistructured interviews at the end of the study captured additional provider perceptions of the AH-HA tool. Posttreatment survivors (breast, prostate, colorectal, endometrial, and lymphomas) completed a survey to assess the acceptability of the AH-HA tool immediately after the designated study appointment. Results: Providers (n=15) reported high overall acceptability of the AH-HA training (mean 5.8, SD 1.0) and tool (mean 5.5, SD 1.4); provider acceptability was also supported by the Unified Theory of Acceptance and Use of Technology scores (eg, effort expectancy: mean 5.6, SD 1.5). Qualitative data also supported provider acceptability of different aspects of the AH-HA tool (eg, “It helps focus the conversation and give the patient a visual of continuum of progress”). Providers were more favorable about using the AH-HA tool for posttreatment survivorship care. Enrolled survivors (n=245) were an average of 4.4 (SD 3.7) years posttreatment. Most survivors reported that they strongly agreed or agreed that they liked the AH-HA tool (n=231, 94.3%). A larger proportion of survivors with high health literacy strongly agreed or agreed that it was helpful to see their heart health score (n=161, 98.2%) compared to survivors with lower health literacy scores (n=68, 89.5%; P=.005). Conclusions: Quantitative surveys and qualitative interview data both demonstrate high acceptability of the AH-HA tool among both providers and survivors. Although most survivors found it helpful to see their heart health score, there may be room for improving communication with survivors who have lower health literacy. Trial Registration: ClinicalTrials.gov NCT03935282; http://clinicaltrials.gov/ct2/show/NCT03935282 International Registered Report Identifier (IRRID): RR2-https://doi-org.wake.idm.oclc.org/10.1016/j.conctc.2021.100808
- 6 March 2025
- Published by JMIR Publications Inc. in Journal of Medical Internet Research
- Vol. 27, e65152
Open AccessOncology Provider and Patient Perspectives on a Cardiovascular Health Assessment Tool Used During Posttreatment Survivorship Care in Community Oncology (Results from WF-1804CD): Mixed Methods Observational Study
Background: Most survivors of cancer have multiple cardiovascular risk factors, increasing their risk of poor cardiovascular and cancer outcomes. The Automated Heart-Health Assessment (AH-HA) tool is a novel electronic health record clinical decision support tool based on the American Heart Association’s Life’s Simple 7 cardiovascular health metrics to promote cardiovascular health assessment and discussion in outpatient oncology. Before proceeding to future implementation trials, it is critical to establish the acceptability of the tool among providers and survivors. Objective: This study aims to assess provider and survivor acceptability of the AH-HA tool and provider training at practices randomized to the AH-HA tool arm within WF-1804CD. Methods: Providers (physicians, nurse practitioners, and physician assistants) completed a survey to assess the acceptability of the AH-HA training, immediately following training. Providers also completed surveys to assess AH-HA tool acceptability and potential sustainability. Tool acceptability was assessed after 30 patients were enrolled at the practice with both a survey developed for the study as well as with domains from the Unified Theory of Acceptance and Use of Technology survey (performance expectancy, effort expectancy, attitude toward using technology, and facilitating conditions). Semistructured interviews at the end of the study captured additional provider perceptions of the AH-HA tool. Posttreatment survivors (breast, prostate, colorectal, endometrial, and lymphomas) completed a survey to assess the acceptability of the AH-HA tool immediately after the designated study appointment. Results: Providers (n=15) reported high overall acceptability of the AH-HA training (mean 5.8, SD 1.0) and tool (mean 5.5, SD 1.4); provider acceptability was also supported by the Unified Theory of Acceptance and Use of Technology scores (eg, effort expectancy: mean 5.6, SD 1.5). Qualitative data also supported provider acceptability of different aspects of the AH-HA tool (eg, “It helps focus the conversation and give the patient a visual of continuum of progress”). Providers were more favorable about using the AH-HA tool for posttreatment survivorship care. Enrolled survivors (n=245) were an average of 4.4 (SD 3.7) years posttreatment. Most survivors reported that they strongly agreed or agreed that they liked the AH-HA tool (n=231, 94.3%). A larger proportion of survivors with high health literacy strongly agreed or agreed that it was helpful to see their heart health score (n=161, 98.2%) compared to survivors with lower health literacy scores (n=68, 89.5%; P=.005). Conclusions: Quantitative surveys and qualitative interview data both demonstrate high acceptability of the AH-HA tool among both providers and survivors. Although most survivors found it helpful to see their heart health score, there may be room for improving communication with survivors who have lower health literacy. Trial Registration: ClinicalTrials.gov NCT03935282; http://clinicaltrials.gov/ct2/show/NCT03935282 International Registered Report Identifier (IRRID): RR2-https://doi-org.wake.idm.oclc.org/10.1016/j.conctc.2021.100808
- 1 January 2025
- Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology
- Vol. 43 (1) , 46-56
Effectiveness of a Cardiovascular Health Electronic Health Record Application for Cancer Survivors in Community Oncology Practice: Results From WF-1804CD
PURPOSE: Guidelines recommend cardiovascular (CV) risk assessment and counseling for cancer survivors. This study evaluated the automated heart-health assessment (AH-HA) clinical decision support tool to promote provider-patient CV health (CVH) discussions in outpatient oncology. METHODS: The AH-HA trial (WF-1804CD), coordinated by the Wake Forest National Cancer Institute Community Oncology Research Program Research Base, randomized practices to the AH-HA tool or usual care (UC) and enrolled survivors receiving routine care ≥6 months after curative cancer treatment. The tool displayed American Heart Association Life's Simple 7 CVH factors (BMI, physical activity, diet, smoking status, blood pressure, cholesterol, and glucose), populated from the electronic health record (EHR), alongside cancer treatments received with cardiotoxic potential. The primary end point was survivor-reported discussion of nonideal or missing CVH factors. A mixed-effects logistic regression model assessed the effect of AH-HA on CVH discussions, adjusting for practice. RESULTS: Five UC and four AH-HA practices enrolled 645 survivors (82% breast, 8% endometrial, 5% colorectal, and 5% lymphoma, prostate, or multiple types) from October 1, 2020, to February 28, 2023. Most survivors were female (96%; 84% White/non-Hispanic, 8% Black; 3% Hispanic). Nearly all survivors (98%) in AH-HA practices reported a discussion for ≥1 nonideal or missing CVH factor compared with 55% in UC ( P < .001). The average number of survivor-reported factors discussed was higher in AH-HA compared with UC (mean, 4.06 v 1.27; P < .001), as were EHR-documented discussions (3.83 v 0.77; P = .03). Survivors in AH-HA practices were also significantly more likely to report a recommendation to see a primary care provider (39%) compared with UC practices (25%, P = .02). Reported recommendations to see a cardiologist were low (approximately 6%) and did not differ between groups. CONCLUSION: The AH-HA tool was effective at promoting CVH discussions during routine follow-up care for survivors and recommendations to consult primary care.
- 1 January 2025
- Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology
- Vol. 43 (1) , 46-56
Effectiveness of a Cardiovascular Health Electronic Health Record Application for Cancer Survivors in Community Oncology Practice: Results From WF-1804CD
PURPOSE: Guidelines recommend cardiovascular (CV) risk assessment and counseling for cancer survivors. This study evaluated the automated heart-health assessment (AH-HA) clinical decision support tool to promote provider-patient CV health (CVH) discussions in outpatient oncology. METHODS: The AH-HA trial (WF-1804CD), coordinated by the Wake Forest National Cancer Institute Community Oncology Research Program Research Base, randomized practices to the AH-HA tool or usual care (UC) and enrolled survivors receiving routine care ≥6 months after curative cancer treatment. The tool displayed American Heart Association Life's Simple 7 CVH factors (BMI, physical activity, diet, smoking status, blood pressure, cholesterol, and glucose), populated from the electronic health record (EHR), alongside cancer treatments received with cardiotoxic potential. The primary end point was survivor-reported discussion of nonideal or missing CVH factors. A mixed-effects logistic regression model assessed the effect of AH-HA on CVH discussions, adjusting for practice. RESULTS: Five UC and four AH-HA practices enrolled 645 survivors (82% breast, 8% endometrial, 5% colorectal, and 5% lymphoma, prostate, or multiple types) from October 1, 2020, to February 28, 2023. Most survivors were female (96%; 84% White/non-Hispanic, 8% Black; 3% Hispanic). Nearly all survivors (98%) in AH-HA practices reported a discussion for ≥1 nonideal or missing CVH factor compared with 55% in UC ( P < .001). The average number of survivor-reported factors discussed was higher in AH-HA compared with UC (mean, 4.06 v 1.27; P < .001), as were EHR-documented discussions (3.83 v 0.77; P = .03). Survivors in AH-HA practices were also significantly more likely to report a recommendation to see a primary care provider (39%) compared with UC practices (25%, P = .02). Reported recommendations to see a cardiologist were low (approximately 6%) and did not differ between groups. CONCLUSION: The AH-HA tool was effective at promoting CVH discussions during routine follow-up care for survivors and recommendations to consult primary care.
- Open Access
- 21 August 2024
- Published by JMIR Publications Inc. in JMIR Preprints
Oncology Provider and Patient Perspectives on a Cardiovascular Health Assessment Tool Used During Posttreatment Survivorship Care in Community Oncology (Results from WF-1804CD): Mixed Methods Observational Study (Preprint)
BACKGROUND Most survivors of cancer have multiple cardiovascular risk factors, increasing their risk of poor cardiovascular and cancer outcomes. The Automated Heart-Health Assessment (AH-HA) tool is a novel electronic health record clinical decision support tool based on the American Heart Association’s Life’s Simple 7 cardiovascular health metrics to promote cardiovascular health assessment and discussion in outpatient oncology. Before proceeding to future implementation trials, it is critical to establish the acceptability of the tool among providers and survivors. OBJECTIVE This study aims to assess provider and survivor acceptability of the AH-HA tool and provider training at practices randomized to the AH-HA tool arm within WF-1804CD. METHODS Providers (physicians, nurse practitioners, and physician assistants) completed a survey to assess the acceptability of the AH-HA training, immediately following training. Providers also completed surveys to assess AH-HA tool acceptability and potential sustainability. Tool acceptability was assessed after 30 patients were enrolled at the practice with both a survey developed for the study as well as with domains from the Unified Theory of Acceptance and Use of Technology survey (performance expectancy, effort expectancy, attitude toward using technology, and facilitating conditions). Semistructured interviews at the end of the study captured additional provider perceptions of the AH-HA tool. Posttreatment survivors (breast, prostate, colorectal, endometrial, and lymphomas) completed a survey to assess the acceptability of the AH-HA tool immediately after the designated study appointment. RESULTS Providers (n=15) reported high overall acceptability of the AH-HA training (mean 5.8, SD 1.0) and tool (mean 5.5, SD 1.4); provider acceptability was also supported by the Unified Theory of Acceptance and Use of Technology scores (eg, effort expectancy: mean 5.6, SD 1.5). Qualitative data also supported provider acceptability of different aspects of the AH-HA tool (eg, “It helps focus the conversation and give the patient a visual of continuum of progress”). Providers were more favorable about using the AH-HA tool for posttreatment survivorship care. Enrolled survivors (n=245) were an average of 4.4 (SD 3.7) years posttreatment. Most survivors reported that they strongly agreed or agreed that they liked the AH-HA tool (n=231, 94.3%). A larger proportion of survivors with high health literacy strongly agreed or agreed that it was helpful to see their heart health score (n=161, 98.2%) compared to survivors with lower health literacy scores (n=68, 89.5%; P=.005). CONCLUSIONS Quantitative surveys and qualitative interview data both demonstrate high acceptability of the AH-HA tool among both providers and survivors. Although most survivors found it helpful to see their heart health score, there may be room for improving communication with survivors who have lower health literacy. CLINICALTRIAL ClinicalTrials.gov NCT03935282; http://clinicaltrials.gov/ct2/show/NCT03935282 INTERNATIONAL REGISTERED REPORT RR2-https://doi-org.wake.idm.oclc.org/10.1016/j.conctc.2021.100808
- 21 August 2024
- Published by JMIR Publications Inc. in JMIR Preprints
Open AccessOncology Provider and Patient Perspectives on a Cardiovascular Health Assessment Tool Used During Posttreatment Survivorship Care in Community Oncology (Results from WF-1804CD): Mixed Methods Observational Study (Preprint)
BACKGROUND Most survivors of cancer have multiple cardiovascular risk factors, increasing their risk of poor cardiovascular and cancer outcomes. The Automated Heart-Health Assessment (AH-HA) tool is a novel electronic health record clinical decision support tool based on the American Heart Association’s Life’s Simple 7 cardiovascular health metrics to promote cardiovascular health assessment and discussion in outpatient oncology. Before proceeding to future implementation trials, it is critical to establish the acceptability of the tool among providers and survivors. OBJECTIVE This study aims to assess provider and survivor acceptability of the AH-HA tool and provider training at practices randomized to the AH-HA tool arm within WF-1804CD. METHODS Providers (physicians, nurse practitioners, and physician assistants) completed a survey to assess the acceptability of the AH-HA training, immediately following training. Providers also completed surveys to assess AH-HA tool acceptability and potential sustainability. Tool acceptability was assessed after 30 patients were enrolled at the practice with both a survey developed for the study as well as with domains from the Unified Theory of Acceptance and Use of Technology survey (performance expectancy, effort expectancy, attitude toward using technology, and facilitating conditions). Semistructured interviews at the end of the study captured additional provider perceptions of the AH-HA tool. Posttreatment survivors (breast, prostate, colorectal, endometrial, and lymphomas) completed a survey to assess the acceptability of the AH-HA tool immediately after the designated study appointment. RESULTS Providers (n=15) reported high overall acceptability of the AH-HA training (mean 5.8, SD 1.0) and tool (mean 5.5, SD 1.4); provider acceptability was also supported by the Unified Theory of Acceptance and Use of Technology scores (eg, effort expectancy: mean 5.6, SD 1.5). Qualitative data also supported provider acceptability of different aspects of the AH-HA tool (eg, “It helps focus the conversation and give the patient a visual of continuum of progress”). Providers were more favorable about using the AH-HA tool for posttreatment survivorship care. Enrolled survivors (n=245) were an average of 4.4 (SD 3.7) years posttreatment. Most survivors reported that they strongly agreed or agreed that they liked the AH-HA tool (n=231, 94.3%). A larger proportion of survivors with high health literacy strongly agreed or agreed that it was helpful to see their heart health score (n=161, 98.2%) compared to survivors with lower health literacy scores (n=68, 89.5%; P=.005). CONCLUSIONS Quantitative surveys and qualitative interview data both demonstrate high acceptability of the AH-HA tool among both providers and survivors. Although most survivors found it helpful to see their heart health score, there may be room for improving communication with survivors who have lower health literacy. CLINICALTRIAL ClinicalTrials.gov NCT03935282; http://clinicaltrials.gov/ct2/show/NCT03935282 INTERNATIONAL REGISTERED REPORT RR2-https://doi-org.wake.idm.oclc.org/10.1016/j.conctc.2021.100808
- Open Access
- 8 June 2023
- Published by Elsevier in Journal of Clinical Anesthesia
- Vol. 89, 111159
Incidence, severity and detection of blood pressure and heart rate perturbations in postoperative ward patients after noncardiac surgery
- 8 June 2023
- Published by Elsevier in Journal of Clinical Anesthesia
- Vol. 89, 111159
Open AccessIncidence, severity and detection of blood pressure and heart rate perturbations in postoperative ward patients after noncardiac surgery
- Open Access
- 17 January 2023
- Published by JMIR Publications Inc. in JMIR Formative Research
- Vol. 7 (1) , e41011
Patient Perspectives on a Targeted Text Messaging Campaign to Encourage Screening for Diabetes: Qualitative Study
Background: A sizeable proportion of prediabetes and diabetes cases among adults in the United States remain undiagnosed. Patient-facing clinical decision support (CDS) tools that leverage electronic health records (EHRs) have the potential to increase diabetes screening. Given the widespread mobile phone ownership across diverse groups, text messages present a viable mode for delivering alerts directly to patients. The use of unsolicited text messages to offer hemoglobin A1c (HbA1c) screening has not yet been studied. It is imperative to gauge perceptions of “cold texts” to ensure that information and language are optimized to promote engagement with text messages that affect follow-through with health behaviors. Objective: This study aims to gauge the perceptions of and receptiveness to text messages to inform content that would facilitate engagement with text messages intended to initiate a mobile health (mHealth) intervention for targeted screening. Messages were designed to invite those not already diagnosed with diabetes to make a decision to take part in HbA1c screening and walk them through the steps required to perform the behavior based solely on an automated text exchange. Methods: In total, 6 focus groups were conducted at Wake Forest Baptist Health (WFBH) between September 2019 and February 2020. The participants were adult patients without diabetes who had completed an in-person visit at the Family and Community Medicine Clinic within the previous year. We displayed a series of text messages and asked the participants to react to the message content and suggest improvements. Content was deductively coded with respect to the Health Belief Model (HBM) and inductively coded to identify other emergent themes that could potentially impact engagement with text messages. Results: Participants (N=36) were generally receptive to the idea of receiving a text-based alert for HbA1c screening. Plain language, personalization, and content, which highlighted perceived benefits over perceived susceptibility and perceived severity, were important to participants’ understanding of and receptiveness to messages. The patient-physician relationship emerged as a recurring theme in which patients either had a desire or held an assumption that their provider would be working behind the scenes throughout each step of the process. Participants needed further clarification to understand the steps involved in following through with HbA1c screening and receiving results. Conclusions: Our findings suggest that patients may be receptive to text messages that alert them to a risk of having an elevated HbA1c in direct-to-patient alerts that use cold texting. Using plain and positive language, integrating elements of personalization, and defining new processes clearly were identified by participants as modifiable content elements that could act as facilitators that would help overcome barriers to engagement with these messages. A patient’s relationship with their provider and the financial costs associated with texts and screening may affect receptiveness and engagement in this process.
- 17 January 2023
- Published by JMIR Publications Inc. in JMIR Formative Research
- Vol. 7 (1) , e41011
Open AccessPatient Perspectives on a Targeted Text Messaging Campaign to Encourage Screening for Diabetes: Qualitative Study
Background: A sizeable proportion of prediabetes and diabetes cases among adults in the United States remain undiagnosed. Patient-facing clinical decision support (CDS) tools that leverage electronic health records (EHRs) have the potential to increase diabetes screening. Given the widespread mobile phone ownership across diverse groups, text messages present a viable mode for delivering alerts directly to patients. The use of unsolicited text messages to offer hemoglobin A1c (HbA1c) screening has not yet been studied. It is imperative to gauge perceptions of “cold texts” to ensure that information and language are optimized to promote engagement with text messages that affect follow-through with health behaviors. Objective: This study aims to gauge the perceptions of and receptiveness to text messages to inform content that would facilitate engagement with text messages intended to initiate a mobile health (mHealth) intervention for targeted screening. Messages were designed to invite those not already diagnosed with diabetes to make a decision to take part in HbA1c screening and walk them through the steps required to perform the behavior based solely on an automated text exchange. Methods: In total, 6 focus groups were conducted at Wake Forest Baptist Health (WFBH) between September 2019 and February 2020. The participants were adult patients without diabetes who had completed an in-person visit at the Family and Community Medicine Clinic within the previous year. We displayed a series of text messages and asked the participants to react to the message content and suggest improvements. Content was deductively coded with respect to the Health Belief Model (HBM) and inductively coded to identify other emergent themes that could potentially impact engagement with text messages. Results: Participants (N=36) were generally receptive to the idea of receiving a text-based alert for HbA1c screening. Plain language, personalization, and content, which highlighted perceived benefits over perceived susceptibility and perceived severity, were important to participants’ understanding of and receptiveness to messages. The patient-physician relationship emerged as a recurring theme in which patients either had a desire or held an assumption that their provider would be working behind the scenes throughout each step of the process. Participants needed further clarification to understand the steps involved in following through with HbA1c screening and receiving results. Conclusions: Our findings suggest that patients may be receptive to text messages that alert them to a risk of having an elevated HbA1c in direct-to-patient alerts that use cold texting. Using plain and positive language, integrating elements of personalization, and defining new processes clearly were identified by participants as modifiable content elements that could act as facilitators that would help overcome barriers to engagement with these messages. A patient’s relationship with their provider and the financial costs associated with texts and screening may affect receptiveness and engagement in this process.
- Open Access
- 14 October 2022
- Published by American Diabetes Association in Clinical Diabetes
- Vol. 40 (4) , 467-476
Impact of the COVID-19 Pandemic on Diabetes Care Among a North Carolina Patient Population
In this study, researchers reviewed electronic health record data to assess whether the coronavirus disease 2019 pandemic was associated with disruptions in diabetes care processes of A1C testing, retinal screening, and nephropathy evaluation among patients receiving care with Wake Forest Baptist Health in North Carolina. Compared with the pre-pandemic period, they found an increase of 13–21 percentage points in the proportion of patients delaying diabetes care for each measure during the pandemic. Alarmingly, delays in A1C testing were greatest for individuals with the most severe disease and may portend an increase in diabetes complications.
- 14 October 2022
- Published by American Diabetes Association in Clinical Diabetes
- Vol. 40 (4) , 467-476
Open AccessImpact of the COVID-19 Pandemic on Diabetes Care Among a North Carolina Patient Population
In this study, researchers reviewed electronic health record data to assess whether the coronavirus disease 2019 pandemic was associated with disruptions in diabetes care processes of A1C testing, retinal screening, and nephropathy evaluation among patients receiving care with Wake Forest Baptist Health in North Carolina. Compared with the pre-pandemic period, they found an increase of 13–21 percentage points in the proportion of patients delaying diabetes care for each measure during the pandemic. Alarmingly, delays in A1C testing were greatest for individuals with the most severe disease and may portend an increase in diabetes complications.